From Casetext: Smarter Legal Research

Dr. Falk Pharma GmbH v. Generico, LLC

United States Court of Appeals for the Federal Circuit
Jun 12, 2019
Appeal No. 2017-2312 (Fed. Cir. Jun. 12, 2019)

Opinion

Appeal No. 2017-2312 Appeal No. 2017-2636 Appeal No. 2018-1320

06-12-2019

DR. FALK PHARMA GMBH, Appellant v. GENERICO, LLC, FLAT LINE CAPITAL LLC, MYLAN PHARMACEUTICALS INC., Appellees SALIX PHARMACEUTICALS, INC., DR. FALK PHARMA GMBH, Plaintiffs-Appellants v. MYLAN PHARMACEUTICALS INC., MYLAN INC., Defendants-Appellees


NOTE: This disposition is nonprecedential. Nonprecedential Opinion

The following change has been made:

Page 16, line 16, "district court" has been changed to "Board."


Summaries of

Dr. Falk Pharma GmbH v. Generico, LLC

United States Court of Appeals for the Federal Circuit
Jun 12, 2019
Appeal No. 2017-2312 (Fed. Cir. Jun. 12, 2019)
Case details for

Dr. Falk Pharma GmbH v. Generico, LLC

Case Details

Full title:DR. FALK PHARMA GMBH, Appellant v. GENERICO, LLC, FLAT LINE CAPITAL LLC…

Court:United States Court of Appeals for the Federal Circuit

Date published: Jun 12, 2019

Citations

Appeal No. 2017-2312 (Fed. Cir. Jun. 12, 2019)